期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Evaluation of the performance of a new serum amyloid A chemiluminescence immunoassay
1
作者 Martina Pelagalli Flaminia Tomassetti +9 位作者 Serena Sarubbi Eleonora Nicolai Alfredo Giovannelli francesco turis Camilla Illuminati Maria Morello Cinzia Callà Alessandro Terrinoni Sergio Bernardini Massimo Pieri 《LabMed Discovery》 2025年第3期16-21,共6页
Objective:Serum amyloid A(SAA)is a protein involved in the acute phase of inflammation.SAA expression is upregulated in humans during the acute phase of various viral infections;in addition,SAA can be a useful biomark... Objective:Serum amyloid A(SAA)is a protein involved in the acute phase of inflammation.SAA expression is upregulated in humans during the acute phase of various viral infections;in addition,SAA can be a useful biomarker to predict the severity and prognosis of COVID-19 patients.This study aimed to evaluate a new chemiluminescence test for SAA detection.Methods:All serum samples were measured for SAA on a Maglumi 800(Snibe,Shenzhen,China)and compared with a BN ProSpec(Siemens,Munich,Germany)in the routine of the clinical laboratory of the University Hospital of the Tor Vergata University of Rome(Rome,Italy).Analytical precision,the correlation coefficient,and linearity were assessed.Statistical analyses were performed.Results:The linearity test was performed via serial dilutions and revealed a correlation coefficient equivalent to 0.9998.The results of the Snibe SAA test correlated well with those obtained by the SAA Siemens test,with a correlation coefficient of 0.974(P<0.001).The intraand interrun precision,as well as carryover,were assessed.-Conclusions:The results obtained from this study demonstrated that the new Snibe SAA test has reliable analytical performance and good accuracy and could represent a valid tool for routine hospital laboratory analysis. 展开更多
关键词 Serum amyloid A(SAA) INFLAMMATION Method validation AUTOMATION Clinical laboratory C-reactive protein(CRP) Erythrocyte sedimentation rate(ESR)
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部